Literature DB >> 10327193

Frequent coexistence of Lewy bodies and neurofibrillary tangles in the same neurons of patients with diffuse Lewy body disease.

E Iseki1, W Marui, K Kosaka, K Uéda.   

Abstract

We examined the frequency of neurons with coexistent Lewy bodies (LB) and neurofibrillary tangles (NFT) in diffuse Lewy body disease brains, by a double-immunostaining method using MDV2 and Human tau. Double-positive neurons were frequently observed in the limbic areas. These neurons mostly revealed the feature of intermingled MDV2- and Human tau-positive substances. Immunoelectron microscopically, the MDV2-positive components were not in continuity with the MDV2-negative paired helical filaments (PHF). The MDV2-positive LB were surrounded by the small PHF bundles, frequently accompanied by the randomly oriented PHF within LB. In the intermingled neurons, MDV2-positive non-filamentous components without LB were found among the large PHF bundles. These non-filamentous components may represent the early stage of LB formation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10327193     DOI: 10.1016/s0304-3940(99)00178-0

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  14 in total

1.  Co-localization of tau and alpha-synuclein in the olfactory bulb in Alzheimer's disease with amygdala Lewy bodies.

Authors:  Hiroshige Fujishiro; Yoshio Tsuboi; Wen-Lang Lin; Hirotake Uchikado; Dennis W Dickson
Journal:  Acta Neuropathol       Date:  2008-04-30       Impact factor: 17.088

2.  Elevated tauopathy and alpha-synuclein pathology in postmortem Parkinson's disease brains with and without dementia.

Authors:  Jonathan Wills; Jessica Jones; Thomas Haggerty; Valeriy Duka; Jeffrey N Joyce; Anita Sidhu
Journal:  Exp Neurol       Date:  2010-06-28       Impact factor: 5.330

3.  Tau and alpha-synuclein pathology in amygdala of Parkinsonism-dementia complex patients of Guam.

Authors:  Mark S Forman; M Luise Schmidt; Sanjay Kasturi; Daniel P Perl; Virginia M-Y Lee; John Q Trojanowski
Journal:  Am J Pathol       Date:  2002-05       Impact factor: 4.307

4.  Alzheimer disease with amygdala Lewy bodies: a distinct form of alpha-synucleinopathy.

Authors:  Hirotake Uchikado; Wen-Lang Lin; Michael W DeLucia; Dennis W Dickson
Journal:  J Neuropathol Exp Neurol       Date:  2006-07       Impact factor: 3.685

5.  TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease.

Authors:  Catalina Amador-Ortiz; Wen-Lang Lin; Zeshan Ahmed; David Personett; Peter Davies; Ranjan Duara; Neill R Graff-Radford; Michael L Hutton; Dennis W Dickson
Journal:  Ann Neurol       Date:  2007-05       Impact factor: 10.422

6.  Concomitant accumulation of α-synuclein and TDP-43 in a patient with corticobasal degeneration.

Authors:  Satoshi Yamashita; Naomi Sakashita; Taro Yamashita; Nozomu Tawara; Masayoshi Tasaki; Kensuke Kawakami; Yoshihiro Komohara; Yukio Fujiwara; Masashi Kamikawa; Takenobu Nakagawa; Teruyuki Hirano; Yasushi Maeda; Masato Hasegawa; Motohiro Takeya; Yukio Ando
Journal:  J Neurol       Date:  2014-09-11       Impact factor: 4.849

7.  The limbic and neocortical contribution of α-synuclein, tau, and amyloid β to disease duration in dementia with Lewy bodies.

Authors:  Tanis J Ferman; Naoya Aoki; Julia E Crook; Melissa E Murray; Neill R Graff-Radford; Jay A van Gerpen; Ryan J Uitti; Zbigniew K Wszolek; Jonathan Graff-Radford; Otto Pedraza; Kejal Kantarci; Bradley F Boeve; Dennis W Dickson
Journal:  Alzheimers Dement       Date:  2017-10-31       Impact factor: 21.566

8.  Tauopathic changes in the striatum of A53T α-synuclein mutant mouse model of Parkinson's disease.

Authors:  Jonathan Wills; Joel Credle; Thomas Haggerty; Jae-Hoon Lee; Adam W Oaks; Anita Sidhu
Journal:  PLoS One       Date:  2011-03-21       Impact factor: 3.240

9.  Region-specific tauopathy and synucleinopathy in brain of the alpha-synuclein overexpressing mouse model of Parkinson's disease.

Authors:  Tiffany Kaul; Joel Credle; Thomas Haggerty; Adam W Oaks; Eliezer Masliah; Anita Sidhu
Journal:  BMC Neurosci       Date:  2011-08-03       Impact factor: 3.288

10.  Oxidative stress in neurodegeneration.

Authors:  Varsha Shukla; Santosh K Mishra; Harish C Pant
Journal:  Adv Pharmacol Sci       Date:  2011-09-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.